Crinetics Pharmaceuticals, Inc. (CRNX)
38.23
-0.67
(-1.72%)
USD |
NASDAQ |
Mar 06, 16:00
38.27
+0.04
(+0.10%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Investing (TTM) : 173.91M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Plus Therapeutics, Inc. | 0.287M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| GT Biopharma, Inc. | 0.00 |
| Axsome Therapeutics, Inc. | -0.48M |
| Sutro Biopharma, Inc. | 113.80M |